Biochemistry of nicotine metabolism and its relevance to lung cancer.
Ontology highlight
ABSTRACT: Nicotine is the key addictive constituent of tobacco. It is not a carcinogen, but it drives smoking and the continued exposure to the many carcinogens present in tobacco. The investigation into nicotine biotransformation has been ongoing for more than 60 years. The dominant pathway of nicotine metabolism in humans is the formation of cotinine, which occurs in two steps. The first step is cytochrome P450 (P450, CYP) 2A6-catalyzed 5'-oxidation to an iminium ion, and the second step is oxidation of the iminium ion to cotinine. The half-life of nicotine is longer in individuals with low P450 2A6 activity, and smokers with low activity often decrease either the intensity of their smoking or the number of cigarettes they use compared with those with "normal" activity. The effect of P450 2A6 acti
SUBMITTER: Murphy SE
PROVIDER: S-EPMC8167289 | biostudies-literature | 2021 Jan-Jun
REPOSITORIES: biostudies-literature
ACCESS DATA